STOCK TITAN

[Form 4] Cerus Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

CERUS CORP reporting person Dean A. Gregory (Director) effected a purchase of 25,000 shares of Cerus common stock on 08/25/2025 at a price of $1.25 per share. After the transaction the reporting person beneficially owned 86,725 shares. The Form 4 was filed by one reporting person and executed by an attorney-in-fact, Chrystal N. Jensen.

La persona che ha presentato la comunicazione per CERUS CORP, Dean A. Gregory (Amministratore), ha acquistato 25.000 azioni ordinarie di Cerus in data 25/08/2025 al prezzo di $1,25 per azione. Dopo l'operazione, la persona che ha presentato la comunicazione deteneva beneficiariamente 86.725 azioni. Il Modulo 4 è stato presentato da un unico soggetto segnalante ed eseguito per procura da Chrystal N. Jensen.

La persona informante de CERUS CORP, Dean A. Gregory (Director), efectuó la compra de 25.000 acciones ordinarias de Cerus el 25/08/2025 a un precio de $1.25 por acción. Tras la operación, la persona informante poseía de forma beneficiaria 86.725 acciones. El Formulario 4 fue presentado por una sola persona informante y firmado mediante apoderada por Chrystal N. Jensen.

CERUS CORP의 보고인 Dean A. Gregory(이사)는 2025-08-25에 Cerus 보통주 25,000주를 주당 $1.25에 매수했습니다. 거래 후 보고인은 86,725주를 실질적으로 보유하게 되었습니다. Form 4는 한 명의 보고인이 제출했으며, 대리인인 Chrystal N. Jensen이 서명했습니다.

La personne déclarante pour CERUS CORP, Dean A. Gregory (Administrateur), a effectué l'achat de 25 000 actions ordinaires de Cerus le 25/08/2025 au prix de 1,25 $ par action. Après la transaction, la personne déclarante détenait bénéficiairement 86 725 actions. Le Formulaire 4 a été déposé par une seule personne déclarante et signé par procuration par Chrystal N. Jensen.

Die meldepflichtige Person von CERUS CORP, Dean A. Gregory (Direktor), erwarb am 25.08.2025 25.000 Stammaktien von Cerus zum Preis von $1,25 pro Aktie. Nach der Transaktion hielt die meldende Person wirtschaftlich 86.725 Aktien. Das Formular 4 wurde von einer meldenden Person eingereicht und durch die Bevollmächtigte Chrystal N. Jensen ausgeführt.

Positive
  • Director purchase of 25,000 shares at $1.25 demonstrates insider acquisition activity
  • Post-transaction beneficial ownership reported as 86,725 shares, providing transparency
Negative
  • None.

Insights

TL;DR: A director purchased 25,000 shares at $1.25, modestly increasing ownership to 86,725 shares.

The disclosure shows a routine insider purchase rather than a sale or option exercise. The size and price are explicit: 25,000 shares at $1.25 each. For a public investor this confirms an insider acquired additional stock, but the filing does not provide context on total outstanding shares or the director's prior holdings beyond the post-transaction total, so material impact on valuation cannot be determined from this form alone.

TL;DR: Director-level insider purchase executed through an attorney-in-fact; filing follows Section 16 reporting format.

The Form 4 is properly completed for a single reporting person and includes the reporting persons relationship as a director and the attorney-in-fact signature. This is a standard Section 16 disclosure showing acquisition code "P" (purchase). No derivative transactions or other changes in beneficial ownership are reported. The filing contains the required details but offers no further governance implications beyond documenting the acquisition.

La persona che ha presentato la comunicazione per CERUS CORP, Dean A. Gregory (Amministratore), ha acquistato 25.000 azioni ordinarie di Cerus in data 25/08/2025 al prezzo di $1,25 per azione. Dopo l'operazione, la persona che ha presentato la comunicazione deteneva beneficiariamente 86.725 azioni. Il Modulo 4 è stato presentato da un unico soggetto segnalante ed eseguito per procura da Chrystal N. Jensen.

La persona informante de CERUS CORP, Dean A. Gregory (Director), efectuó la compra de 25.000 acciones ordinarias de Cerus el 25/08/2025 a un precio de $1.25 por acción. Tras la operación, la persona informante poseía de forma beneficiaria 86.725 acciones. El Formulario 4 fue presentado por una sola persona informante y firmado mediante apoderada por Chrystal N. Jensen.

CERUS CORP의 보고인 Dean A. Gregory(이사)는 2025-08-25에 Cerus 보통주 25,000주를 주당 $1.25에 매수했습니다. 거래 후 보고인은 86,725주를 실질적으로 보유하게 되었습니다. Form 4는 한 명의 보고인이 제출했으며, 대리인인 Chrystal N. Jensen이 서명했습니다.

La personne déclarante pour CERUS CORP, Dean A. Gregory (Administrateur), a effectué l'achat de 25 000 actions ordinaires de Cerus le 25/08/2025 au prix de 1,25 $ par action. Après la transaction, la personne déclarante détenait bénéficiairement 86 725 actions. Le Formulaire 4 a été déposé par une seule personne déclarante et signé par procuration par Chrystal N. Jensen.

Die meldepflichtige Person von CERUS CORP, Dean A. Gregory (Direktor), erwarb am 25.08.2025 25.000 Stammaktien von Cerus zum Preis von $1,25 pro Aktie. Nach der Transaktion hielt die meldende Person wirtschaftlich 86.725 Aktien. Das Formular 4 wurde von einer meldenden Person eingereicht und durch die Bevollmächtigte Chrystal N. Jensen ausgeführt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gregory Dean A.

(Last) (First) (Middle)
C/O CERUS CORPORATION
1220 CONCORD AVE SUITE 600

(Street)
CONCORD CA 94520

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CERUS CORP [ CERS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 P 25,000 A $1.25 86,725 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Dean A. Gregory by Chrystal N. Jensen, attorney-in-fact 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cerus Corp (CERS) insider Dean A. Gregory do on 08/25/2025?

The director purchased 25,000 shares of Cerus common stock at $1.25 per share on 08/25/2025.

How many Cerus shares does the reporting person own after the transaction?

After the reported purchase the reporting person beneficially owned 86,725 shares.

Who signed the Form 4 for the reporting person?

The Form 4 was executed by attorney-in-fact Chrystal N. Jensen on behalf of Dean A. Gregory.

Was the Form 4 filed by one reporting person or multiple persons?

The form indicates it was filed by one reporting person.

Does the filing report any derivative transactions for CERS?

No. Table II for derivative securities contains no entries in this filing.
Cerus

NASDAQ:CERS

CERS Rankings

CERS Latest News

CERS Latest SEC Filings

CERS Stock Data

245.37M
182.73M
3.33%
73.65%
3.65%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
CONCORD